Proportions of circulating subsets of DCs (mDCs and pDCs) and their expression of adhesion molecules (VLA-4 and LFA-1) at baseline and during natalizumab therapy (NTZ = 6) in MS patients, healthy controls (HC = 10), and untreated RRMS controls (MSC = 4). The gene discussed is ITGAL; the disease is myeloid sarcoma.